CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $70.60 billion. The enterprise value is $138.34 billion.
Market Cap | 70.60B |
Enterprise Value | 138.34B |
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, before market open.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | Oct 21, 2024 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -2.15% in one year.
Shares Outstanding | 1.26B |
Shares Change (YoY) | -2.15% |
Shares Change (QoQ) | -0.63% |
Owned by Insiders (%) | 0.11% |
Owned by Institutions (%) | 82.88% |
Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 9.97 and the forward PE ratio is 8.46. CVS Health's PEG ratio is 2.27.
PE Ratio | 9.97 |
Forward PE | 8.46 |
PS Ratio | 0.20 |
Forward PS | 0.18 |
PB Ratio | 0.94 |
P/FCF Ratio | 13.39 |
PEG Ratio | 2.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.59, with an EV/FCF ratio of 26.24.
EV / Earnings | 19.24 |
EV / Sales | 0.38 |
EV / EBITDA | 8.59 |
EV / EBIT | 11.98 |
EV / FCF | 26.24 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.12.
Current Ratio | 0.86 |
Quick Ratio | 0.60 |
Debt / Equity | 1.12 |
Debt / EBITDA | 4.36 |
Debt / FCF | 15.90 |
Interest Coverage | 4.08 |
Financial Efficiency
Return on equity (ROE) is 9.73% and return on invested capital (ROIC) is 4.60%.
Return on Equity (ROE) | 9.73% |
Return on Assets (ROA) | 2.87% |
Return on Capital (ROIC) | 4.60% |
Revenue Per Employee | $1.21M |
Profits Per Employee | $23,967 |
Employee Count | 300,000 |
Asset Turnover | 1.44 |
Inventory Turnover | 18.58 |
Taxes
In the past 12 months, CVS Health has paid $2.44 billion in taxes.
Income Tax | 2.44B |
Effective Tax Rate | 25.28% |
Stock Price Statistics
The stock price has decreased by -18.65% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | -18.65% |
50-Day Moving Average | 59.86 |
200-Day Moving Average | 64.90 |
Relative Strength Index (RSI) | 31.66 |
Average Volume (20 Days) | 14,514,304 |
Short Selling Information
The latest short interest is 19.75 million, so 1.57% of the outstanding shares have been sold short.
Short Interest | 19.75M |
Short Previous Month | 18.50M |
Short % of Shares Out | 1.57% |
Short % of Float | 1.57% |
Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, CVS Health had revenue of $361.86 billion and earned $7.19 billion in profits. Earnings per share was $5.63.
Revenue | 361.86B |
Gross Profit | 52.00B |
Operating Income | 11.55B |
Pretax Income | 9.63B |
Net Income | 7.19B |
EBITDA | 16.10B |
EBIT | 11.55B |
Earnings Per Share (EPS) | $5.63 |
Balance Sheet
The company has $16.26 billion in cash and $83.82 billion in debt, giving a net cash position of -$67.56 billion or -$53.71 per share.
Cash & Cash Equivalents | 16.26B |
Total Debt | 83.82B |
Net Cash | -67.56B |
Net Cash Per Share | -$53.71 |
Equity (Book Value) | 75.11B |
Book Value Per Share | 59.66 |
Working Capital | -11.43B |
Cash Flow
In the last 12 months, operating cash flow was $8.07 billion and capital expenditures -$2.80 billion, giving a free cash flow of $5.27 billion.
Operating Cash Flow | 8.07B |
Capital Expenditures | -2.80B |
Free Cash Flow | 5.27B |
FCF Per Share | $4.19 |
Margins
Gross margin is 14.37%, with operating and profit margins of 3.19% and 1.99%.
Gross Margin | 14.37% |
Operating Margin | 3.19% |
Pretax Margin | 2.66% |
Profit Margin | 1.99% |
EBITDA Margin | 4.45% |
EBIT Margin | 3.19% |
FCF Margin | 1.45% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 4.74%.
Dividend Per Share | $2.66 |
Dividend Yield | 4.74% |
Dividend Growth (YoY) | 9.92% |
Years of Dividend Growth | 2 |
Payout Ratio | 47.23% |
Buyback Yield | 2.15% |
Shareholder Yield | 6.89% |
Earnings Yield | 10.18% |
FCF Yield | 7.47% |
Analyst Forecast
The average price target for CVS Health is $75.39, which is 34.34% higher than the current price. The consensus rating is "Buy".
Price Target | $75.39 |
Price Target Difference | 34.34% |
Analyst Consensus | Buy |
Analyst Count | 18 |
Revenue Growth Forecast (5Y) | 5.06% |
EPS Growth Forecast (5Y) | 10.38% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
Last Split Date | Jun 7, 2005 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.18 |
Piotroski F-Score | 6 |